Shou Jiafeng, Zhang Qi, Wang Shuai, Zhang Dahong
Department of Urology, Zhejiang Provincial People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang Province, People's Republic of China.
Prostate. 2018 May;78(7):491-497. doi: 10.1002/pros.23492. Epub 2018 Feb 13.
The present of metastases is a poor prognostic factor in prostate cancer, but the prognostic impact of different distant metastases pattern is unclear. The aim of this study is to investigate the impact of different distant metastases pattern on the survival of patients with stage IV prostate cancer.
Data queried for this study include prostate cancer (2010-2014) from the Surveillance, Epidemiology, and End Results (SEER) program. Metastatic distribution information was provided for bone, brain, liver and lung. The overall survival was calculated by the Kaplan-Meier method. Multivariable Cox regression models were used to analyze survival outcome and risk factors.
A total of 265 900 eligible patients were identified from SEER database. Among these patients, stage of IV prostate cancer accounted for 7.53% (20 034/265 900) at diagnosis. Patients who suffered metastasis to either one of the four organs occupied 61.24% (12 268/20 034) in stage of IV patients. Comparing with other three single metastases, the patients with liver metastasis exhibited worst OS whose mean survival was 17.529 months (P < 0.001). The mean survival of metastases with bong and lung was 25.238 months, which was the best survival of the six forms with two metastatic sites (P < 0.001). The results of univariate survival analysis showed that metastatic forms, race, N-classification and differentiated grade did not have impact on the overall survival of patients with three metastatic sites (all, P > 0.05).
In analysis of both one and two metastatic sites, patients with liver metastasis seemed to have worse survival outcome. On the other hand, bone metastasis had better outcome than other three visceral metastases. Knowledge of these differences in metastatic patterns may help to better guide pre-treatment evaluation of prostate cancer and make determination regarding curative-intent interventions.
转移灶的存在是前列腺癌的一个不良预后因素,但不同远处转移模式的预后影响尚不清楚。本研究的目的是探讨不同远处转移模式对IV期前列腺癌患者生存的影响。
本研究查询的数据包括来自监测、流行病学和最终结果(SEER)计划的前列腺癌(2010 - 2014年)。提供了骨、脑、肝和肺的转移分布信息。采用Kaplan-Meier方法计算总生存期。多变量Cox回归模型用于分析生存结果和危险因素。
从SEER数据库中确定了总共265900例符合条件的患者。在这些患者中,IV期前列腺癌在诊断时占7.53%(20034/265900)。IV期患者中,有四个器官之一发生转移的患者占61.24%(12268/20034)。与其他三种单一转移相比,肝转移患者的总生存期最差,平均生存期为17.529个月(P < 0.001)。骨和肺转移患者的平均生存期为25.238个月,是六种双转移部位形式中生存期最好的(P < 0.001)。单因素生存分析结果显示,转移形式、种族、N分级和分化程度对三个转移部位患者的总生存期没有影响(均P > 0.05)。
在对一个和两个转移部位的分析中,肝转移患者的生存结果似乎较差。另一方面,骨转移的结果优于其他三种内脏转移。了解这些转移模式的差异可能有助于更好地指导前列腺癌的治疗前评估,并对根治性干预做出决策。